Remifentanil: a review of its analgesic and sedative use in the perioperative period

Adequate perioperative pain relief is an integral part of anesthesia. Opioid analgesics occupy one of the key places in the purchase of acute and chronic pain in the world. The article presents current data on the clinical effectiveness of remifentanil, a derivative of fentanyl, which is a selectiv...

Full description

Bibliographic Details
Main Authors: Dmytro Dmytriiev, Oleksandr Nazarchuk, Yuliana Babina, Kateryna Dmytriieva
Format: Article
Language:Russian
Published: Interdisciplinary Academy of Pain Medicine 2024-01-01
Series:Perioperative Medicine
Subjects:
Online Access:https://perioperative.org.ua/index.php/prtmdc/article/view/116
_version_ 1797349573131239424
author Dmytro Dmytriiev
Oleksandr Nazarchuk
Yuliana Babina
Kateryna Dmytriieva
author_facet Dmytro Dmytriiev
Oleksandr Nazarchuk
Yuliana Babina
Kateryna Dmytriieva
author_sort Dmytro Dmytriiev
collection DOAJ
description Adequate perioperative pain relief is an integral part of anesthesia. Opioid analgesics occupy one of the key places in the purchase of acute and chronic pain in the world. The article presents current data on the clinical effectiveness of remifentanil, a derivative of fentanyl, which is a selective ultra-short-acting μ-opioid receptor agonist when used in the perioperative period for the treatment of acute and chronic pain. Comparisons of the therapeutic activity and physicochemical properties, pharmacokinetic and pharmacodynamic characteristics of remifentanil with other opioids (fentanyl, sufentanil, alfentanil) are provided. Its unique properties (eg, organ function-independent metabolism, non-accumulation, rapid onset of action, and short duration of action) distinguish it from other opioid agents. Remifentanil is at least as effective as comparator opioids such as fentanyl, sufentanil in relieving pain and sedating patients during the perioperative period. In addition, it provides rapid and predictable extubation and is associated with shorter duration of mechanical ventilation and shorter length of hospitalization than comparators in some studies. In addition, remifentanil is well tolerated in both adults and children. Thus, remifentanil is a desirable addition to currently available pharmacologic agents used to treat period pain in patients
first_indexed 2024-03-08T12:32:15Z
format Article
id doaj.art-586e5407a6fd447bb0bbe94a19b5c3e9
institution Directory Open Access Journal
issn 2616-339X
2617-2925
language Russian
last_indexed 2024-03-08T12:32:15Z
publishDate 2024-01-01
publisher Interdisciplinary Academy of Pain Medicine
record_format Article
series Perioperative Medicine
spelling doaj.art-586e5407a6fd447bb0bbe94a19b5c3e92024-01-21T16:01:27ZrusInterdisciplinary Academy of Pain MedicinePerioperative Medicine2616-339X2617-29252024-01-016210.31636/prmd.v6i2.2Remifentanil: a review of its analgesic and sedative use in the perioperative periodDmytro Dmytriiev0Oleksandr Nazarchuk1Yuliana Babina2Kateryna Dmytriieva3National Pirogov Memorial Medical University, Vinnytsia, UkraineNational Pirogov Memorial Medical University, Vinnytsia, UkraineNational Pirogov Memorial Medical University, Vinnytsia, UkraineNational Pirogov Memorial Medical University, Vinnytsia, Ukraine Adequate perioperative pain relief is an integral part of anesthesia. Opioid analgesics occupy one of the key places in the purchase of acute and chronic pain in the world. The article presents current data on the clinical effectiveness of remifentanil, a derivative of fentanyl, which is a selective ultra-short-acting μ-opioid receptor agonist when used in the perioperative period for the treatment of acute and chronic pain. Comparisons of the therapeutic activity and physicochemical properties, pharmacokinetic and pharmacodynamic characteristics of remifentanil with other opioids (fentanyl, sufentanil, alfentanil) are provided. Its unique properties (eg, organ function-independent metabolism, non-accumulation, rapid onset of action, and short duration of action) distinguish it from other opioid agents. Remifentanil is at least as effective as comparator opioids such as fentanyl, sufentanil in relieving pain and sedating patients during the perioperative period. In addition, it provides rapid and predictable extubation and is associated with shorter duration of mechanical ventilation and shorter length of hospitalization than comparators in some studies. In addition, remifentanil is well tolerated in both adults and children. Thus, remifentanil is a desirable addition to currently available pharmacologic agents used to treat period pain in patients https://perioperative.org.ua/index.php/prtmdc/article/view/116opioid analgesicsremifentanilgeneral anesthesia
spellingShingle Dmytro Dmytriiev
Oleksandr Nazarchuk
Yuliana Babina
Kateryna Dmytriieva
Remifentanil: a review of its analgesic and sedative use in the perioperative period
Perioperative Medicine
opioid analgesics
remifentanil
general anesthesia
title Remifentanil: a review of its analgesic and sedative use in the perioperative period
title_full Remifentanil: a review of its analgesic and sedative use in the perioperative period
title_fullStr Remifentanil: a review of its analgesic and sedative use in the perioperative period
title_full_unstemmed Remifentanil: a review of its analgesic and sedative use in the perioperative period
title_short Remifentanil: a review of its analgesic and sedative use in the perioperative period
title_sort remifentanil a review of its analgesic and sedative use in the perioperative period
topic opioid analgesics
remifentanil
general anesthesia
url https://perioperative.org.ua/index.php/prtmdc/article/view/116
work_keys_str_mv AT dmytrodmytriiev remifentanilareviewofitsanalgesicandsedativeuseintheperioperativeperiod
AT oleksandrnazarchuk remifentanilareviewofitsanalgesicandsedativeuseintheperioperativeperiod
AT yulianababina remifentanilareviewofitsanalgesicandsedativeuseintheperioperativeperiod
AT katerynadmytriieva remifentanilareviewofitsanalgesicandsedativeuseintheperioperativeperiod